Literature DB >> 6731181

Histamine and its catabolism in tumour-bearing rat and mouse.

C Maśliński, D Kierska, K Sasiak, B Adamas.   

Abstract

The hypothesis that failure of histamine (Hi)-mediated inter and intracellular cell-cell communication may be involved in the control of cellular growth has been tested in leukaemia-bearing mice and fibrosarcoma-bearing rats. In all examined tissues of mice bearing leukaemia L1210 cells and rats bearing methylcholanthrene fibrosarcoma histamine content was higher than in controls. Tissues of fibrosarcoma-bearing rats more intensively metabolized 14C-Hi and oxidative pathway was predominant. Histamine metabolic activity as well as histamine catabolic pathways do not differ in leukaemic mice as compared with the controls.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6731181     DOI: 10.1007/BF01973858

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  13 in total

1.  A method for the fluorometric assay of histamine in tissues.

Authors:  P A SHORE; A BURKHALTER; V H COHN
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

Review 2.  Junctional intercellular communication and the control of growth.

Authors:  W R Loewenstein
Journal:  Biochim Biophys Acta       Date:  1979-02-04

3.  Changes in ornithine decarboxylase activity in normal tissues of tumor-bearing mice during tumor growth.

Authors:  T Noguchi; A Kashiwagi; T Tanaka
Journal:  J Biochem       Date:  1976-02       Impact factor: 3.387

4.  Catabolism of 3 H-histamine in the rat brain after intracisternal administration.

Authors:  J C Schwartz; H Pollard; S Bischoff; M C Rehault; M Verdiere-Sahuque
Journal:  Eur J Pharmacol       Date:  1971 Nov-Dec       Impact factor: 4.432

5.  Biogenesis and physiology of histamine.

Authors:  G Kahlson; E Rosengren
Journal:  Monogr Physiol Soc       Date:  1971

6.  Partial purificationand characterizationof a factor which stimulates an increase in ornithine decarboxylase activity in the liver from tumor cell-free ascites fluid.

Authors:  A Kashiwagi; K Sasaki; T Noguchi; T Tanaka
Journal:  Biochim Biophys Acta       Date:  1979-01-18

7.  Levels of histaminase and L-DOPA decarboxylase activity in the transition from C-cell hyperplasia to familial medullary thyroid carcinoma.

Authors:  S B Baylin; G Mendelsohn; W R Weisburger; D S Gann; J C Eggleston
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

8.  Hog kidney diamine oxidase conversion of biogenic diamines to inhibitors of cell proliferation.

Authors:  J M Gaugas; D L Dewey
Journal:  J Pathol       Date:  1981-07       Impact factor: 7.996

9.  Histamine levels in blood and other tissues of male and female C3H mice. II. Mice carrying a 3-methyl-cholanthrene-induced tumor [proceedings].

Authors:  P Scheinmann; B Lebel; N R Lynch; J C Salomon; J R Paupe; C Burtin
Journal:  Agents Actions       Date:  1979-04

10.  The influence of carcinoma growth on diamine oxidase activity in human gastrointestinal tract.

Authors:  J Kusche; T Biegański; R Hesterberg; C D Stahlknecht; K D Feussner; I Stahlenberg; W Lorenz
Journal:  Agents Actions       Date:  1980-04
View more
  5 in total

1.  Causal relationship between a tumour growth and the changes in histamine metabolism in tissues of sarcoma-bearing rat.

Authors:  D Kierska; K Sasiak; T Biegański; C Maśliński
Journal:  Agents Actions       Date:  1987-04

2.  Histamine in C3H/W mice carrying spontaneous tumors of the mammary gland.

Authors:  C Maslinski; D Kierska
Journal:  Agents Actions       Date:  1991-05

3.  Induction and quail liver diamine oxidase (histaminase). Part II: Different responses to the inducers.

Authors:  G Ignesti; F Buffoni; M Perretti; A Cintelli
Journal:  Agents Actions       Date:  1988-08

4.  Decreased histamine content and metabolism in mammary cancer tissue from C3H mice.

Authors:  D Kierska; H Szymańska; C Maslinski
Journal:  Agents Actions       Date:  1992-11

5.  Blood histamine and solid malignant tumors.

Authors:  C M Moriarty; J L Stucky; K W Hamburger; K D Patil; J F Foley; R R Koefoot
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.